About Teleia

Teleia (teh-LAY-uh) comes from the Greek word for complete: something brought all the way to its end. Its root is telos, the Greek word for an end or a goal.

That is the whole idea. A positive multi-cancer blood test is not a diagnosis. It is the start of a workup that can take weeks or months, moving through imaging, specialists and sometimes a biopsy before a patient gets a real answer. Along the way, steps stall and patients wait without knowing what comes next.

Teleia follows every positive result until it is complete. It lays out the workup for the predicted cancer site with every step tied to its published source, gives each step an owner and a due date, flags anything that stalls, keeps the patient informed in plain language, and records the final answer. Nothing is decided by software. A clinician reviews every plan and signs every outcome.

No result left unfinished. No patient left waiting without a next step.

Teleia works with any multi-cancer early detection test and is built for the health systems, navigators and physicians who carry patients from a positive result to an answer.

Teleia is built by Vindicara Inc. in Los Angeles.